Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer| AGENUS (NASDAQ: AGEN) | Delayed: 6.68 +0.18 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.50 | 52 Week High | $7.49 | |||
| Open | $6.52 | 52 Week Low | $2.61 | |||
| Day High | $6.99 | P/E | N/A | |||
| Day Low | $6.51 | EPS | $-1.10 | |||
| Volume | 815,432 | |||||
| (NASDAQ: GANX) | Delayed: 1.33 +0.01 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $ | |||
| Open | $1.32 | 52 Week Low | $ | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.31 | EPS | $ | |||
| Volume | 510,726 | |||||



